Medline Inc. (MDLN) exhibits 26.4% gross margins and 8.2% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 20.3x enterprise multiple and 7.3% implied options volatility.
Sustained 26.4% gross profitability converts into 7.8% operating margin and 8.2% ROIC, outpacing sector cost of capital.
ROIC: 8.2% // GM: 26.4%YoY revenue trajectory of +11.5% paired with 3.08% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +11.5% // FCF YLD: 3.08%Altman Z-Score of 2.50 and Piotroski F-Score of 5/9 indicate low near-term refinancing stress.
ALTMAN Z: 2.50 // F-SCORE: 5/9Trading at 4.5x trailing P/E (4.2x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 4.5x // EV/EBITDA: 20.3xOptions market prices a ±7.3% implied move with a 0.81 put/call ratio around $31.00 max pain.
IMPL MOVE: ±7.3% // P/C: 0.81Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend 68.0% net margins.
NET MARGIN: 68.0% // D/E: 1.16x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for MDLN & activate live FRED threshold breach alerts.